spacer
home > ict > media info
MEDIA INFORMATION

WHY ADVERTISE?

ICT occupies a crucial position in pharmaceutical publishing, offering an advertising platform to contract product and service providers from across the clinical trials market. Its targeted circulation to key global decision-makers guarantees maximum exposure for your company. Furthermore, ICTís media partnerships with key industry events provide advertisers with bonus distribution opportunities throughout the year.

ICTís presence online offers exciting digital opportunities. With a comprehensive company directory, and press releases and events listing facilities, the website is the ideal platform to showcase banners and logos. The website is complemented by the magazineís ebook Ė an interactive digital edition of ICT that opens up a whole host of rich media advertising options.

     

READERSHIP: JOB FUNCTIONS

Business Development 
Clinical Research
Corporate Management/CEO
Drug Safety
Industry Consultancy
IT/Data Management
Laboratory
Management

 

Marketing and Sales
Preclinical/Clinical Trial/Clinical Supply 
Product Development
Project Management
Purchasing/Supplies
QA/QC
R&D


 
 



   

ADVERTISING RATES

 

WEB SITE FACILITIES

SIZE
RATE
FRONT COVER LOGO 
 £1,500
DOUBLE PAGE SPREAD
£4,550
SINGLE PAGE
£2,850
HALF PAGE
£1,575
QUARTER PAGE
£895
OPPOSITE CONTENT PAGES
£3,750
OPPOSITE EDITORíS LETTER
£3,750
INSIDE FRONT COVER
£5,950
INSIDE BACK COVER
£3,450
OUTSIDE BACK COVER
£6,750

 

1) Hyperlink from a relevant section of our website to client website
2) Banner and/or logo on our website (see below for banner specifications)
3) Client news page Ė to use for press releases during the duration of advertising.
4) Corporate profile up to 350 words

Banner Specifications 
GIF or JPEG (if static) or SWF (flash), 468x60 or 200x150 pixels.

     

REPROGRAPHIC MECHANICAL SPECIFICATIONS

MECHANICAL DETAILS (IN MM)

Type Size
Trim Size
Bleed Size

Double Page*

273 x 396
297 x 420
303 x 426

One Page

273 x 186
297 x 210
303 x 213

1/2 page (horizontal)

135 x 186
148 x 210
151 x 213

1/2 page (vertical)

273 x 92
297 x 105
303 x 108

1/4 page

135 x 92
N/A
N/A


Electronic pictures or graphics can be supplied in the following formats:

1. Adobe Photoshop CS2 TIFF (*.tif), JPEG, PSD or EPS
2. Adobe Illustrator CS2 EPS

Electronic images/graphics must be supplied at high resolution (at least 300dpi)
Electronic images/graphics should be in CMYK colour.
Please do not send picture files embedded in Microsoft Word documents.
Please supply them as separate attachments.

Pictures can be supplied as good quality colour or black and white photographs

Client designed adverts should be supplied in one of the following ways:

1. QuarkXpress 6 (not Quark Passport) - Relevant high resolution graphics and fonts must also be supplied.

2. Adobe Illustrator CS2 - Images and graphics must be embedded. Fonts should be supplied if they are not embedded/converted to outline.

3. Adobe Acrobat PDF - Advert PDFs must be supplied optimised for high quality printing. All colours (including pictures) must be CMYK, and not RGB or Pantone. Graphics must be high resolution (300dpi), with all fonts embedded. Bleed adverts must include registration markings and bleed. We are unable to make ammendments to PDF files.

All adverts should be supplied with a colour copy of the advert. PDFs are supplied entirely at the clientís own risk and the publisher accepts no responsibility for any errors in printing. Electronic files can be emailed to us. Larger files (above 10Mb) should be supplied to us on CD.

spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August and November
 
Industry Events

SMiís 5th Molecular Diagnostics Conference

9-11 July 2018, Holiday Inn Kensington Forum, London, UK

SMi is proud to announce their 5th Molecular Diagnostics conference. The event will take place in central London on Monday 9th and Tuesday 10th July 2018, along with two half-day post-conference workshops taking place on Wednesday 11th July 2018
More info >>

 
News and Press Releases

RoslinCT to Participate in the Northern Alliance Advanced Therapies Treatment Centre

RoslinCT, a UK-based cell and gene therapy contract manufacturing organisation, is delighted to be part of the Northern Alliance Advanced Therapies Treatment Centre (NAATTC) consortium. As an industry partner within the consortium, RoslinCT will provide advice on the development, manufacture and clinical supply of cell, gene and tissue engineered therapies.
More info >>

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement